In multivariate logistic regression analyses, low ALT was associated with an increased risk of severe COVID-19, with increased mortality (OR 1.88, 95% CI 1.37–2.56) and prolonged hospitalization (OR 1.78, 95% CI 1.33–2.35). This evidence concerns the gene GPT and COVID-19.